Menu Search
Equities

Torrent Pharmaceuticals Ltd

TORNTPHARM:NSI

Torrent Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)3,151.05
  • Today's Change4.95 / 0.16%
  • Shares traded382.16k
  • 1 Year change+53.63%
  • Beta0.4880
Data delayed at least 15 minutes, as of Nov 12 2024 10:17 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Torrent Pharmaceuticals Ltd grew revenues 11.51% from 96.20bn to 107.28bn while net income improved 33.02% from 12.45bn to 16.56bn.
Gross margin75.52%
Net profit margin16.06%
Operating margin24.80%
Return on assets12.08%
Return on equity25.37%
Return on investment17.95%
More ▼

Cash flow in INRView more

In 2024, Torrent Pharmaceuticals Ltd increased its cash reserves by 64.23%, or 3.27bn. The company earned 32.66bn from its operations for a Cash Flow Margin of 30.44%. In addition the company used 1.68bn on investing activities and also paid 27.80bn in financing cash flows.
Cash flow per share76.84
Price/Cash flow per share41.01
Book value per share221.72
Tangible book value per share83.65
More ▼

Balance sheet in INRView more

Torrent Pharmaceuticals Ltd has a Debt to Total Capital ratio of 29.41%, a lower figure than the previous year's 32.22%.
Current ratio1.21
Quick ratio0.7444
Total debt/total equity0.4166
Total debt/total capital0.2941
More ▼

Growth rates in INR

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 27.27% and 33.02%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
Div yield(5 year avg)1.19%
Div growth rate (5 year)26.93%
Payout ratio (TTM)11.27%
EPS growth(5 years)30.58
EPS (TTM) vs
TTM 1 year ago		34.13
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.